Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Novartis to acquire Cadent Therapeutics in $770m deal to bolster neuropsychiatric pipeline Find out how Novartis plans to transform neuroscience with its $770M acquisition of Cadent Therapeutics and its novel CNS treatment pipeline. bypharmanewsdailyDecember 19, 2020
